ImmunoGen Inc - Company Profile

Powered by

All the sales intelligence you need on ImmunoGen Inc in one solution.

$195 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how ImmunoGen Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with ImmunoGen Inc.

Back to companies

ImmunoGen Inc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

ImmunoGen Inc, a subsidiary of AbbVie Inc operates within the pharmaceuticals and healthcare industry, specifically focusing on the therapy area of oncology and gastrointestinal tract cancer. It is committed to researching, developing, and manufacturing effective treatments for colorectal cancer patients. The company is headquartered in the US.

 Gain a 360-degree view of ImmunoGen Inc and make more informed decisions for your business Gain a 360-degree view of ImmunoGen Inc and make more informed decisions for your business Learn more
Headquarters United States of America
Address 830 Winter Street, Waltham, Massachusetts, 02451-1477
Website www.immunogen.com
Telephone 1 781 8950600
Industry Pharmaceuticals and Healthcare
   
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Learn more

ImmunoGen Inc premium industry data and analytics

80+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for ImmunoGen Inc’s relevant decision makers and contact details.

80+

Catalyst Calendar

Proactively evaluate ImmunoGen Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

60+

Pipeline Drugs

Identify which of ImmunoGen Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

40+

Clinical Trials

Determine ImmunoGen Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

12+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

3

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

1

Marketed Drugs

Understand ImmunoGen Inc’s commercialized product portfolio to stay one step ahead of the market.

Image for loader
Executives
Name Position Board Since Age
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into ImmunoGen Inc key executives to enhance your sales strategy Gain insight into ImmunoGen Inc key executives to enhance your sales strategy Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?